| Strain Source | Uniprot ID | Length (AA) | Expression System | Tag Type |
|---|---|---|---|---|
| ATCC 10987 | Q72XV7 | 270 | E. coli | Undisclosed |
| G9842 | B7IPS6 | Partial | Baculovirus | Determined during production |
Lgt1 modifies prolipoproteins by attaching a diacylglyceryl moiety to a conserved cysteine residue within the lipobox motif ([LVI][ASTVI][GAS]C) . This step is indispensable for:
Membrane Localization: Lipoproteins are routed to the outer membrane via the Lol transport system .
Toxin Secretion: Lgt1 activity indirectly regulates virulence factors like hemolysin BL (HBL) and non-hemolytic enterotoxin (Nhe) . Strains lacking functional Lgt1 show reduced cytotoxicity due to impaired toxin secretion .
Antibiotic Resistance: Lipoproteins stabilize the outer membrane; Lgt1 inhibition disrupts membrane integrity, enhancing susceptibility to antibiotics and host immune defenses .
Recombinant Lgt1 enables in vitro studies of its enzymatic mechanism. For example:
Activity Measurement: A coupled luciferase assay detects glycerol phosphate release during diacylglyceryl transfer . Inhibitors like G9066 and G2823 show IC₅₀ values of 0.24 μM and 0.93 μM, respectively .
Inhibitor Screening: Identified Lgt inhibitors (Lgti) are bactericidal against E. coli and A. baumannii, validating Lgt1 as a drug target .
Gene Knockout Effects: Depleting lgt1 in B. cereus reduces HBL-mediated NLRP3 inflammasome activation and host cell pyroptosis .
Regulatory Networks: Lgt1 activity intersects with transcriptional regulators like PlcR and ResD, which control toxin gene expression .
While recombinant Lgt1 has advanced antibacterial drug development, unresolved questions remain:
KEGG: bca:BCE_5266
Prolipoprotein diacylglyceryl transferase 1 (lgt1) is a critical enzyme in Bacillus cereus that catalyzes the first step in bacterial lipoprotein biosynthesis. This enzyme attaches lipid anchors (diacylglyceryl groups) to prolipoproteins, creating lipoproteins that play crucial roles in bacterial physiology and virulence. The function of lgt1 in B. cereus is similar to that observed in related Bacillus species, such as B. anthracis, where the enzyme facilitates the attachment of lipid anchors to prolipoproteins, enabling proper cellular localization and function .
In Bacillus species, lipoprotein biosynthesis follows a conserved pathway:
Prolipoprotein synthesis occurs with an N-terminal signal peptide containing a lipobox motif
The prolipoprotein diacylglyceryl transferase (lgt) attaches a diacylglyceryl group to the conserved cysteine residue in the lipobox
Signal peptidase II cleaves the signal peptide, leaving the modified cysteine at the N-terminus
For some lipoproteins in certain bacteria, additional modifications may occur
Research with B. anthracis has demonstrated that disruption of this pathway through lgt deletion results in bacteria lacking lipoproteins, as confirmed by 14C-palmitate labeling, and exhibiting decreased surface hydrophobicity . This pattern is expected to be similar in B. cereus given the genetic relatedness between these species.
Bacterial lipoproteins serve as crucial mediators of virulence in many Gram-positive bacteria, including Bacillus species. These functions include:
| Function | Virulence Contribution |
|---|---|
| Immunomodulation | Trigger TLR2-dependent inflammatory responses |
| Nutrient acquisition | Facilitate uptake of essential nutrients during infection |
| Adhesion | Mediate attachment to host tissues |
| Spore germination | Support efficient spore germination in host environments |
Studies in B. anthracis show that deletion of the lgt gene significantly reduces TLR2-dependent TNF-α responses from macrophages exposed to the bacteria. Additionally, spores of lgt mutants exhibit inefficient germination both in vitro and in mouse models, leading to attenuated virulence in subcutaneous infection models . Similar mechanisms likely operate in B. cereus, particularly considering its presence in ready-to-eat foods where it can cause food poisoning .
The lgt gene shows high conservation across the Bacillus cereus group, which includes B. cereus, B. anthracis, and B. thuringiensis. This conservation reflects the essential nature of lipoprotein biosynthesis in bacterial physiology. While specific sequence comparisons aren't provided in the search results, research on B. anthracis indicates that disruption of the lgt gene affects bacterial properties similarly to what would be expected in related species, suggesting functional conservation . The B. cereus group is known to share many virulence factors and physiological systems, with MLST analysis showing genetic relationships among strains .
When designing experiments to study lgt1 function in B. cereus, follow these structured approaches:
Define variables clearly:
Formulate specific, testable hypotheses:
Example: "Deletion of lgt1 in B. cereus will reduce lipoprotein anchoring as measured by 14C-palmitate labeling"
Design experimental treatments:
Assign subjects to experimental groups:
Plan measurements:
Creating and validating an lgt1 deletion mutant in B. cereus involves several critical steps:
Generation of the mutant:
Design primers targeting regions flanking the lgt1 gene
Amplify these regions and join them in a deletion construct
Clone the construct into a suicide vector containing a selectable marker
Introduce the vector into B. cereus through electroporation
Select for single crossover integrants using appropriate antibiotics
Counter-select for double crossover events to obtain clean deletion mutants
Validation protocols:
PCR verification using primers flanking the deleted region
Whole-genome sequencing to confirm clean deletion without additional mutations
Complementation with functional lgt1 to verify phenotype restoration
14C-palmitate labeling to confirm absence of lipoproteins (as demonstrated in B. anthracis)
Hydrocarbon partitioning to measure changes in surface hydrophobicity
This comprehensive validation ensures the observed phenotypes are specifically due to lgt1 deletion rather than polar effects or secondary mutations.
Several experimental approaches can effectively assess the role of lgt1 in B. cereus virulence:
In vitro techniques:
Lipoprotein quantification: Use 14C-palmitate labeling to confirm lipoprotein anchoring
Toxin production analysis: Measure levels of enterotoxins (NHE, HBL, CytK, EntFM) and emetic toxin (cereulide) using ELISA or gene expression assays
Macrophage response assays: Assess TLR2-dependent TNF-α production by macrophages exposed to wild-type versus lgt1 mutant bacteria
Germination efficiency tests: Compare spore germination rates in vitro under various conditions
In vivo techniques:
Murine infection models: Assess virulence using established models such as:
Subcutaneous infection model to compare lesion formation and dissemination
Gastrointestinal infection model to evaluate food poisoning capacity
Germination assessment in vivo: Analyze spore germination efficiency in mouse skin or other tissues
Comprehensive phenotypic analysis should include comparing vegetative cells versus spores, as research in B. anthracis indicates different virulence impacts depending on the bacterial form .
When studying recombinant lgt1 activity, the following controls are essential:
Negative controls:
Reaction mixture without the recombinant lgt1 enzyme
Heat-inactivated recombinant lgt1 to confirm enzyme specificity
Recombinant lgt1 with site-directed mutations in catalytic residues
Substrate analogs lacking the lipobox motif required for modification
Positive controls:
Known functional lgt from related species (e.g., B. anthracis lgt)
Well-characterized synthetic substrates with confirmed lipobox motifs
Naturative native B. cereus lipoproteins for in vitro assay calibration
Experimental validation controls:
Mass spectrometry to confirm diacylglyceryl transfer to target proteins
Size-exclusion chromatography to verify protein folding and oligomeric state
Circular dichroism to assess secondary structure integrity
Calibration curves for quantitative enzymatic activity measurements
These controls help validate assay specificity, ensure enzyme functionality, and provide benchmarks for comparing experimental results across different conditions or enzyme variants.
The role of lgt1 in B. cereus food poisoning virulence involves multiple mechanisms:
B. cereus causes food poisoning through two primary mechanisms: the diarrheal syndrome (mediated by enterotoxins) and the emetic syndrome (caused by cereulide). Lipoproteins processed by lgt1 likely contribute to both pathways:
Enterotoxin production regulation: While the enterotoxins themselves (NHE, HBL, CytK, EntFM) are not typically lipoproteins, their production and secretion may be influenced by lipoprotein-dependent signaling systems. Studies show that 83% of B. cereus isolates harbor the nheABC gene cluster, and all possess the entFM gene, indicating widespread enterotoxin potential .
Spore germination efficiency: Research in B. anthracis demonstrates that lgt deletion impairs spore germination both in vitro and in vivo . Similarly, B. cereus spores in food likely require efficient lipoprotein processing for optimal germination in the gastrointestinal tract. Inefficient germination would reduce vegetative cell numbers and subsequent toxin production.
Adaptation to food environments: B. cereus has been detected in 35% of ready-to-eat food samples across China, with contamination levels between 3-1100 MPN/g in 68% of positive samples and exceeding 1100 MPN/g in 10% of samples . Lipoproteins likely contribute to adaptation to these food matrices, influencing survival and subsequent virulence.
Understanding these mechanisms can inform food safety measures and therapeutic strategies for B. cereus food poisoning.
The relationship between lgt1 function and antibiotic resistance in B. cereus involves several interconnected mechanisms:
Cell envelope integrity: Lipoproteins contribute to cell envelope structure, potentially affecting antibiotic permeability
Efflux pump regulation: Some lipoproteins may participate in regulatory networks controlling expression of efflux systems
Stress response coordination: Lipoproteins often function in stress response pathways that can confer transient antibiotic tolerance
Experimental considerations for studying this relationship:
Compare minimum inhibitory concentrations (MICs) between wild-type and lgt1 mutant strains across multiple antibiotic classes
Analyze expression of resistance genes in the presence and absence of functional lgt1
Assess membrane permeability changes in lgt1 mutants that might affect antibiotic penetration
Investigate whether antibiotic exposure alters lgt1 expression or activity
This research direction could reveal novel approaches to combat B. cereus antibiotic resistance, which is particularly concerning given its presence in ready-to-eat foods .
Genetic polymorphisms in lgt1 could significantly impact B. cereus virulence through several mechanisms:
Potential impacts of lgt1 polymorphisms:
Altered substrate specificity: Mutations in the substrate-binding pocket could change the range of prolipoproteins modified by lgt1
Enzyme efficiency variation: Polymorphisms affecting catalytic residues or protein stability might alter the rate of lipoprotein processing
Strain-specific virulence patterns: Different lgt1 variants might contribute to the diverse virulence profiles observed across B. cereus strains
Analysis approaches for studying lgt1 polymorphisms:
Multilocus sequence typing (MLST): B. cereus shows significant genetic diversity, with studies identifying 192 different sequence types (STs) among 368 isolates . Correlating lgt1 sequence variants with these STs could reveal patterns of evolution and selection.
Structure-function analysis: Map polymorphisms onto protein structure models to predict functional impacts
Recombinant expression of variants: Compare enzymatic activity of different natural lgt1 variants in standardized assays
Complementation studies: Introduce different lgt1 variants into deletion mutants to assess their relative capacity to restore wild-type phenotypes
This research direction could help explain the varying levels of virulence observed among B. cereus strains and potentially identify high-risk variants for enhanced surveillance.
The interactions between lgt1 and toxin production systems in B. cereus reveal complex regulatory networks:
While direct experimental evidence of lgt1-toxin interactions is limited in the search results, we can infer potential relationships based on known B. cereus toxin systems:
Diarrheal toxin interactions:
The widespread distribution of enterotoxin genes in B. cereus isolates (nheABC in 83%, hblACD in 39%, cytK in 68%, and entFM in 100% of strains) suggests these systems are fundamental to virulence
Lipoproteins processed by lgt1 may function in sensing environmental cues that trigger enterotoxin production
Toxin secretion pathways might include lipoprotein components requiring lgt1 processing
Emetic toxin interactions:
The emetic toxin cereulide (encoded by cesB) is found in only 7% of B. cereus strains , suggesting a more specialized virulence mechanism
ST26 strains frequently harbor the cesB gene and are associated with food poisoning causing vomiting
Lipoproteins might contribute to regulating cereulide production in response to specific food components, particularly starch-containing foods
These interactions represent promising research targets for understanding B. cereus pathogenicity and developing intervention strategies for food safety applications.
Recombinant lgt1 expression and purification present several challenges due to the enzyme's membrane association. Here are systematic approaches to overcome common issues:
Expression challenges and solutions:
| Challenge | Solution Approach |
|---|---|
| Poor solubility | 1. Use membrane protein expression vectors with solubility tags (MBP, SUMO) |
| 2. Express in specialized E. coli strains (C41/C43) designed for membrane proteins | |
| 3. Reduce induction temperature to 16-20°C and extend expression time | |
| Protein misfolding | 1. Co-express with molecular chaperones (GroEL/ES, DnaK/J) |
| 2. Include mild detergents in lysis buffer (0.5-1% Triton X-100) | |
| 3. Test various buffer compositions to enhance stability | |
| Low yield | 1. Optimize codon usage for expression host |
| 2. Test different promoter systems (T7, tac, araBAD) | |
| 3. Scale up culture volume with optimized conditions |
Purification strategies:
Two-step purification combining affinity chromatography with size exclusion or ion exchange
Incorporate appropriate detergents (DDM, LDAO) throughout purification to maintain native conformation
Add glycerol (10-20%) to all buffers to enhance protein stability
Include reducing agents to prevent disulfide-mediated aggregation
Validate activity after each purification step to ensure enzyme functionality
This methodical approach helps overcome the inherent challenges of working with membrane-associated enzymes like lgt1, maximizing the chances of obtaining functional protein for downstream analyses.
Analyzing contradictory results in lgt1 functional studies requires systematic investigation of experimental variables:
Systematic troubleshooting approach:
Genetic background verification:
Methodological considerations:
Variable phenotype explanations:
Consider strain-specific genetic context effects
Investigate threshold effects in lipoprotein processing
Examine potential functional redundancy with other enzymes
Resolution strategies:
Design critical experiments addressing specific contradictions
Perform side-by-side comparisons under identical conditions
Implement multiple complementary assays to measure the same parameter
Collaborate with laboratories reporting contradictory results for direct comparison
This structured approach can identify the sources of contradictory results and establish consensus on lgt1 function across different experimental contexts.
Quantitative analysis of lgt1 enzymatic activity requires rigorous assay design and careful data interpretation:
In vitro enzymatic assays:
Radiometric assay: Measure incorporation of radiolabeled lipids (e.g., 14C-palmitate) into substrate proteins
Quantify using scintillation counting or phosphorimaging
Calculate specific activity (nmol product/min/mg enzyme)
Fluorescence-based assay: Use fluorescently labeled substrate analogs
Monitor real-time kinetics through fluorescence changes
Determine Km, Vmax, and catalytic efficiency (kcat/Km)
Mass spectrometry approach: Detect mass shifts corresponding to diacylglyceryl addition
Provides direct evidence of substrate modification
Can be quantitative when using internal standards
Data analysis framework:
Apply appropriate statistical methods for comparing activity under different conditions:
ANOVA for multiple condition comparisons
Linear regression for examining correlations with experimental variables
Non-linear regression for enzyme kinetics modeling
Control for confounding variables:
Substrate availability and concentration
Membrane/detergent composition effects
Enzyme stability over assay duration
This comprehensive approach enables reliable quantification of lgt1 activity across diverse experimental conditions, facilitating mechanistic insights and structure-function relationships.
Bioinformatic analysis of lgt1 provides valuable insights into conservation and function:
Sequence analysis tools:
Multiple sequence alignment:
MUSCLE or Clustal Omega for aligning lgt1 sequences across Bacillus species
Jalview for visualization and conservation analysis
Identification of invariant catalytic residues and substrate-binding motifs
Phylogenetic analysis:
Structure prediction:
AlphaFold or RoseTTAFold for generating structural models
SWISS-MODEL for homology modeling if related structures exist
Molecular dynamics simulations to predict functional motions
Functional annotation tools:
Domain identification:
InterProScan to identify conserved domains and motifs
Pfam for family classification and functional annotation
Genomic context analysis:
MicrobesOnline or STRING for examining gene neighborhoods
Identification of potential functional partners through co-occurrence patterns
Virulence prediction:
VirulenceFinder or VFDB for comparing to known virulence factors
Correlation with clinical isolate data to identify pathogenicity-associated variants
These bioinformatic approaches complement experimental studies and can guide hypothesis generation for further functional characterization of lgt1.